Acronym INMARE
Category
Marine Biotechnology
Title Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea Programme H2020
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source European Coordinator Peter Golyshin Coordinator email p.golyshin@bangor.ac.uk
Coordinator institution
NA
Institutions involved
NA - Bayer Public Company (Germany) ,
NA - Evoxx Technologies Gmbh (Germany) ,
HHU - Heinrich Heine University Düsseldorf (Germany) ,
CLIB - Industrial Biotechnology Cluster (Germany) ,
NA - Inofea AG (Switzerland) ,
IST-ID - Instituto Superior Técnico for Research and Development Association (Portugal) ,
NA - Jacobs University (Germany) ,
LSE - London School of Economics and Political Science (United Kingdom) ,
CNR - National Research Council (Italy) ,
NORCE - Norwegian Research Centre (Norway) ,
Novozymes - Novozymes AS (Denmark) ,
NA - Pharma Mar SA (Spain) ,
NA - Seascape Belgium (Belgium) ,
CSIC - Spanish National Research Council (Spain) ,
UniR - Uni Research Centre for Applied Biology, Bergen (Norway) ,
UCC - University College Cork (Ireland) ,
FHNW - University of Applied Sciences Northwestern Switzerland (Switzerland) ,
UiB - University of Bergen (Norway) ,
UNIBO - University of Bologna (Italy) ,
UHH - University of Hamburg (Germany) ,
UNIMI - University of Milan (Italy) ,
U of T - University of Toronto (Canada) ,
NA - Vilnius University (Lithuania) ,
Start year 2015 End year 2019 Funding (€) € 7,330,387 Website https://cordis.europa.eu/project/id/634486 Summary The INMARE consortium will unify multidisciplinary expertise and facilities, including advanced technologies to access and sample unique marine biodiversity hot-spots; state-of-the art technologies for construction of metagenomic libraries; innovative enzyme screening assays and platforms; cutting-edge sequence annotation pipelines and bioinformatics resources; high-end activity screening technology; bioanalytical and bioprocess engineering facilities and expertise, nanoparticle-biocatalysts; high-quality protein crystallization and structural analysis facilities and experts in IP management for biotechnology.
The companies involved in the project are market leaders in enzyme production and biocatalysis to more efficiently deliver safer (pharmaceuticals, cheaper (agriculture) and biobased (biopolymers) products. In addition, all participating companies feel responsible and committed to render chemical processes greener.
Further industrial partners involved, have impressive track records in natural products discovery for biomedical, especially anti-cancer (with the production of the first antitumor medicine from marine resources), environmental cleanup applications and public dissemination of science and in increasing the public awareness and interest in research.
Keywords
Genomic;
Bioprospecting;
Bioprocess;
Biocatalyses;
Protein;
Metagenomic;
Fungus;
Marine enzymes;
Biodiversity;
Bioactive compounds;
Biomaterial;
Bioproduct;
Algae;
Sponge;
Bacteria;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
